ReviewNeuro-oncology advances

Pathways to hypermutation in high-grade gliomas: Mechanisms, syndromes, and opportunities for immunotherapy.

Tuesday Haynes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.